- ADCT-301 in Patients With Advanced Triple Negative Breast Cancer
- Anetumab Ravtansine in Advanced Triple Negative Tumors That Are Mesothelin-Positive
- A Vaccine-Based Immunotherapy For Stage IV Triple Negative Breast Cancer
- Durvalumab & Olaparib in Advanced Triple Negative Breast Cancer Treated with Chemotherapy
- LAG525 plus Spartalizumab or Carboplatin in Advanced Triple-Negative Breast Cancer
- Tavo and Pembrolizumab (Immunotherapy) in Advanced Triple Negative Tumors
Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.
Last Modified on August 25, 2020